Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference85 articles.
1. Allemani C, Matsuda T, di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet 2018;391. 10.1016/S0140-6736(17)33326-3.
2. Veronesi U, Zurrida S. Optimal surgical treatment of breast cancer. The Oncologist 1996;1. 10.1634/theoncologist.1-6-340.
3. Giuliano AE, Ballman K v., McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA - J Am Med Assoc 2017;318. 10.1001/jama.2017.11470.
4. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23–01): 10-year follow-up of a randomised, controlled phase 3 trial;Galimberti;Lancet Oncol,2018
5. Solá M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: Final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surgical Oncology 2013;20. 10.1245/s10434-012-2569-y.